MHRA Exclusive: Spotlight on Effective Biobanking Operations and Regulatory Compliance

SMi’s 6th Biobanking conference returns to London on 20th – 21st June at the Holiday Inn Kensington Forum.

London, United Kingdom, April 23, 2016 --(PR.com)-- Following the success of previous events, SMi’s BioBanking conference returns to London on 20th and 21st June 2016. The two-day conference will once again gather a global audience of leading industry experts including regulatory decision-makers, scientific researchers, and academia, providing the perfect platform to explore the latest developments and ethical guidelines in biobanking processes to improve R&D outcomes.

This year’s agenda has been tailored to reflect industry-specific challenges, particularly the impact of impending regulatory changes brought forth by the EU Data Protection Act.

In addition to hearing case studies on legislative updates, this year’s event will feature three presentations from industry leaders at the heart of effective biobanking operations.

1. Assuring long term supply chain of stem cells with National Institute for Biological Standards and Control – MHRA

Professor Glyn Stacey, Director of the UK Stem Cell Bank (Division of Advanced Therapies) will explore key issues relating to cryo-conservation of stem cell cultures and establishing appropriate systems for successful stem cell bank operations.

2. Biobanking in drug development
H. Lundback A/S Biobank Manager Dr Michael Luntang-Jensen talks about the integration of biobanking in drug development with a focus on organisational and logistic requirements for high quality sample management, regulatory challenges and governance.

3. The first European Bank for induced Pluripotent Stem Cells (EBiSC)
With the recent launch of EBiSC's catalogue of induced Pluripotent Stem Cells, Aidan Courtney, CEO of Roslin Sciences and Dr Bryan Bolton, Head of BD - Culture Collection of Public Health England host a spotlight session on how they created the bank and factors influencing long-term sustainability of biobanks.

Other speakers include the European Commission, Roche Diagnostics, MSD USA, AstraZeneca, UK Biobank, Auria Biobank and other leading European biobanks. The full list of speakers and their topics can be viewed on http://www.bio-banking-event.com/prcom.

This unmissable and timely conference is CPD-certified. For those interested in attending the event, there is currently a £300 saving available online which expires on 29 April. Visit http://www.bio-banking-event.com/prcom to register.
For details on tailored sponsorship and branding packages, please contact Alia Malick on +44 (0) 207 827 6168 or email amalick@smi-online.co.uk

6th BioBanking Conference and Exhibition
London, UK
20-21 June 2016
http://www.bio-banking-event.com/prcom

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6102
http://www.bio-banking-event.com/prcom
ContactContact
Categories